| On-demand preexposure prophylaxis in men at high risk for HIV-1 infection JM Molina, C Capitant, B Spire, G Pialoux, L Cotte, I Charreau, ... New England Journal of Medicine 373 (23), 2237-2246, 2015 | 1879 | 2015 |
| Maraviroc for previously treated patients with R5 HIV-1 infection RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ... New England Journal of Medicine 359 (14), 1429-1441, 2008 | 926 | 2008 |
| High rates of forward transmission events after acute/early HIV-1 infection BG Brenner, M Roger, JP Routy, D Moisi, M Ntemgwa, C Matte, JG Baril, ... The Journal of infectious diseases 195 (7), 951-959, 2007 | 885 | 2007 |
| Evolution and transmission of stable CTL escape mutations in HIV infection PJR Goulder, C Brander, Y Tang, C Tremblay, RA Colbert, MM Addo, ... Nature 412 (6844), 334-338, 2001 | 703 | 2001 |
| Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study JM Molina, I Charreau, B Spire, L Cotte, J Chas, C Capitant, C Tremblay, ... The lancet HIV 4 (9), e402-e410, 2017 | 503 | 2017 |
| Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case–control study using Quebec's public health … M Durand, O Sheehy, JG Baril, J Lelorier, CL Tremblay JAIDS Journal of Acquired Immune Deficiency Syndromes 57 (3), 245-253, 2011 | 354 | 2011 |
| Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 JM Strizki, C Tremblay, S Xu, L Wojcik, N Wagner, W Gonsiorek, ... Antimicrobial agents and chemotherapy 49 (12), 4911-4919, 2005 | 309 | 2005 |
| Hepatitis C virus genotype 7, a new genotype originating from central Africa DG Murphy, E Sablon, J Chamberland, E Fournier, R Dandavino, ... Journal of clinical microbiology 53 (3), 967-972, 2015 | 276 | 2015 |
| Wide variation in the multiplicity of HIV-1 infection among injection drug users KJ Bar, H Li, A Chamberland, C Tremblay, JP Routy, T Grayson, C Sun, ... Journal of virology 84 (12), 6241-6247, 2010 | 273 | 2010 |
| On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial JM Molina, C Capitant, B Spire, G Pialoux, C Chidiac, I Charreau, ... Conference on retroviruses and opportunistic infections 2015, 2015 | 263 | 2015 |
| Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis DHS Tan, MW Hull, D Yoong, C Tremblay, P O’byrne, R Thomas, J Kille, ... Cmaj 189 (47), E1448-E1458, 2017 | 225 | 2017 |
| The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals M Veillette, M Coutu, J Richard, LA Batraville, O Dagher, N Bernard, ... Journal of virology 89 (1), 545-551, 2015 | 197 | 2015 |
| Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals G Beaudoin-Bussières, A Laumaea, SP Anand, J Prévost, R Gasser, ... MBio 11 (5), 10.1128/mbio. 02590-20, 2020 | 185 | 2020 |
| A side by side comparison of Bruker Biotyper and VITEK MS: utility of MALDI-TOF MS technology for microorganism identification in a public health reference laboratory S Lévesque, PJ Dufresne, H Soualhine, MC Domingo, S Bekal, ... PloS one 10 (12), e0144878, 2015 | 183 | 2015 |
| Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study A Iannello, MR Boulassel, S Samarani, O Debbeche, C Tremblay, E Toma, ... The Journal of immunology 184 (1), 114-126, 2010 | 181 | 2010 |
| Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset SP Anand, J Prévost, M Nayrac, G Beaudoin-Bussières, M Benlarbi, ... Cell Reports Medicine 2 (6), 2021 | 180 | 2021 |
| CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction Y Peretz, Z He, Y Shi, B Yassine-Diab, JP Goulet, R Bordi, ... Public Library of Science 8 (8), e1002840, 2012 | 174 | 2012 |
| A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Cell host & microbe 29 (7), 1137-1150. e6, 2021 | 171 | 2021 |
| Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100 CL Tremblay, C Kollmann, F Giguel, TC Chou, MS Hirsch JAIDS Journal of Acquired Immune Deficiency Syndromes 25 (2), 99-102, 2000 | 154 | 2000 |
| Clinical Characteristics at Initial Presentation and Impact of Dual Therapy on the Outcome of Bacteremic Streptococcus pneumoniae Pneumonia in Adults K Weiss, DE Low, L Cortes, A Beaupre, R Gauthier, P Gregoire, M Legare, ... Canadian respiratory journal 11 (8), 589-593, 2004 | 139 | 2004 |
